Thyrocare Technologies · NSE: THYROCARE · BSE: 539871
Q4 FY24 results · Jan–Mar 2024
Thyrocare Technologies reported revenue from operations of ₹154.25 crore (up 13.5% from Q4 FY23) and net profit of ₹17.18 crore (up 37.6% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 154.25 | 135.88 | +13.5% | 134.74 | +14.5% |
| Other income | 3.49 | 3.70 | −5.7% | 2.73 | +27.8% |
| Total income | 157.74 | 139.58 | +13.0% | 137.47 | +14.7% |
| Profit before tax | 22.90 | 16.92 | +35.3% | 19.78 | +15.8% |
| Net profit for the period | 17.18 | 12.49 | +37.6% | 14.74 | +16.6% |
| Attributable to shareholders of the company | 17.79 | 12.60 | +41.2% | 15.35 | +15.9% |
| EPS, basic (₹) | 3.54 | 2.36 | +50.0% | 2.78 | +27.3% |
| Net margin (%) | 11.1 | 9.2 | 10.9 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 141.23 | 124.82 | +13.1% | 122.89 | +14.9% |
| Other income | 2.81 | 2.07 | +35.7% | 2.09 | +34.4% |
| Total income | 144.04 | 126.89 | +13.5% | 124.98 | +15.3% |
| Profit before tax | 25.05 | 14.82 | +69.0% | 20.76 | +20.7% |
| Net profit for the period | 19.23 | 9.93 | +93.7% | 14.89 | +29.1% |
| EPS, basic (₹) | 3.63 | 1.88 | +93.1% | 2.81 | +29.2% |
| Net margin (%) | 13.6 | 8.0 | 12.1 |
Consolidated
- Filed with BSE
- 16 May 2024, 11:49 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 May 2024, 11:49 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE